Microbiota modulation counteracts Alzheimer's disease progression influencing neuronal proteolysis and gut hormones plasma levels
Laura Bonfili, Valentina Cecarini, Sara Berardi, Silvia Scarpona, Jan S Suchodolski, Cinzia Nasuti, Dennis Fiorini, Maria Chiara Boarelli, Giacomo Rossi, Anna Maria Eleuteri, Laura Bonfili, Valentina Cecarini, Sara Berardi, Silvia Scarpona, Jan S Suchodolski, Cinzia Nasuti, Dennis Fiorini, Maria Chiara Boarelli, Giacomo Rossi, Anna Maria Eleuteri
Abstract
Gut microbiota has a proven role in regulating multiple neuro-chemical pathways through the highly interconnected gut-brain axis. Oral bacteriotherapy thus has potential in the treatment of central nervous system-related pathologies, such as Alzheimer's disease (AD). Current AD treatments aim to prevent onset, delay progression and ameliorate symptoms. In this work, 3xTg-AD mice in the early stage of AD were treated with SLAB51 probiotic formulation, thereby affecting the composition of gut microbiota and its metabolites. This influenced plasma concentration of inflammatory cytokines and key metabolic hormones considered therapeutic targets in neurodegeneration. Treated mice showed partial restoration of two impaired neuronal proteolytic pathways (the ubiquitin proteasome system and autophagy). Their cognitive decline was decreased compared with controls, due to a reduction in brain damage and reduced accumulation of amyloid beta aggregates. Collectively, our results clearly prove that modulation of the microbiota induces positive effects on neuronal pathways that are able to slow down the progression of Alzheimer's disease.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
References
- Cecarini V, et al. Crosstalk between the ubiquitin-proteasome system and autophagy in a human cellular model of Alzheimer’s disease. Biochimica et biophysica acta. 2012;1822:1741–1751. doi: 10.1016/j.bbadis.2012.07.015.
- Zheng Q, Li J, Wang X. Interplay between the ubiquitin-proteasome system and autophagy in proteinopathies. International journal of physiology, pathophysiology and pharmacology. 2009;1:127–142.
- Nilsson P, et al. Abeta secretion and plaque formation depend on autophagy. Cell reports. 2013;5:61–69. doi: 10.1016/j.celrep.2013.08.042.
- van Tijn P, et al. Mutant ubiquitin decreases amyloid beta plaque formation in a transgenic mouse model of Alzheimer’s disease. Neurochemistry international. 2012;61:739–748. doi: 10.1016/j.neuint.2012.07.007.
- Gomes S, et al. Protective effect of leptin and ghrelin against toxicity induced by amyloid-beta oligomers in a hypothalamic cell line. Journal of neuroendocrinology. 2014;26:176–185. doi: 10.1111/jne.12138.
- Folch J, et al. The role of leptin in the sporadic form of Alzheimer’s disease. Interactions with the adipokines amylin, ghrelin and the pituitary hormone prolactin. Life sciences. 2015
- Theodoropoulou A, Metallinos IC, Psyrogiannis A, Vagenakis GA, Kyriazopoulou V. Ghrelin and leptin secretion in patients with moderate Alzheimer’s disease. The journal of nutrition, health & aging. 2012;16:472–477. doi: 10.1007/s12603-012-0058-4.
- Stoyanova. Ghrelin: A link between ageing, metabolism and neurodegenerative disorders. Neurobiology of Disease, 1–12 (2014).
- Moon M, et al. Ghrelin ameliorates cognitive dysfunction and neurodegeneration in intrahippocampal amyloid-beta1-42 oligomer-injected mice. Journal of Alzheimer’s disease: JAD. 2011;23:147–159.
- Niedowicz DM, et al. Leptin regulates amyloid beta production via the gamma-secretase complex. Biochimica et biophysica acta. 2013;1832:439–444. doi: 10.1016/j.bbadis.2012.12.009.
- Fewlass DC, et al. Obesity-related leptin regulates Alzheimer’s Abeta. FASEB journal: official publication of the Federation of American Societies for Experimental Biology. 2004;18:1870–1878. doi: 10.1096/fj.04-2572com.
- Greco SJ, et al. Leptin reduces pathology and improves memory in a transgenic mouse model of Alzheimer’s disease. Journal of Alzheimer’s disease: JAD. 2010;19:1155–1167. doi: 10.3233/JAD-2010-1308.
- Rigamonti AE, et al. Plasma ghrelin concentrations in elderly subjects: comparison with anorexic and obese patients. The Journal of endocrinology. 2002;175:R1–5. doi: 10.1677/joe.0.175R001.
- Perry T, et al. Glucagon-like peptide-1 decreases endogenous amyloid-beta peptide (Abeta) levels and protects hippocampal neurons from death induced by Abeta and iron. Journal of neuroscience research. 2003;72:603–612. doi: 10.1002/jnr.10611.
- Abbas T, Faivre E, Holscher C. Impairment of synaptic plasticity and memory formation in GLP-1 receptor KO mice: Interaction between type 2 diabetes and Alzheimer’s disease. Behavioural brain research. 2009;205:265–271. doi: 10.1016/j.bbr.2009.06.035.
- Gault VA, Holscher C. Protease-resistant glucose-dependent insulinotropic polypeptide agonists facilitate hippocampal LTP and reverse the impairment of LTP induced by beta-amyloid. Journal of neurophysiology. 2008;99:1590–1595. doi: 10.1152/jn.01161.2007.
- Faivre E, Holscher C. Neuroprotective effects of D-Ala(2)GIP on Alzheimer’s disease biomarkers in an APP/PS1 mouse model. Alzheimer’s research & therapy. 2013;5:20. doi: 10.1186/alzrt174.
- Bhattacharjee S, Lukiw WJ. Alzheimer’s disease and the microbiome. Frontiers in cellular neuroscience. 2013;7:153. doi: 10.3389/fncel.2013.00153.
- Wang Y, Kasper LH. The role of microbiome in central nervous system disorders. Brain, behavior, and immunity. 2014;38:1–12. doi: 10.1016/j.bbi.2013.12.015.
- Kang SS, et al. Diet and exercise orthogonally alter the gut microbiome and reveal independent associations with anxiety and cognition. Molecular neurodegeneration. 2014;9:36. doi: 10.1186/1750-1326-9-36.
- Tang, M. L. et al. Administration of a probiotic with peanut oral immunotherapy: A randomized trial. The Journal of allergy and clinical immunology135, 737–744 e738, doi:10.1016/j.jaci.2014.11.034 (2015).
- Penha Filho, R. A. et al. Immunomodulatory activity and control of Salmonella Enteritidis colonization in the intestinal tract of chickens by Lactobacillus based probiotic. Veterinary immunology and immunopathology, doi:10.1016/j.vetimm.2015.06.006 (2015).
- Fedorak, R. N. et al. The probiotic VSL#3 has anti-inflammatory effects and could reduce endoscopic recurrence after surgery for Crohn’s disease. Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association13, 928–935 e922, doi:10.1016/j.cgh.2014.10.031 (2015).
- Rossi G, et al. Comparison of microbiological, histological, and immunomodulatory parameters in response to treatment with either combination therapy with prednisone and metronidazole or probiotic VSL#3 strains in dogs with idiopathic inflammatory bowel disease. PloS one. 2014;9:e94699. doi: 10.1371/journal.pone.0094699.
- Talero E, et al. Inhibition of chronic ulcerative colitis-associated adenocarcinoma development in mice by VSL#3. Inflammatory bowel diseases. 2015;21:1027–1037. doi: 10.1097/MIB.0000000000000346.
- Duncan SH, Flint HJ. Probiotics and prebiotics and health in ageing populations. Maturitas. 2013;75:44–50. doi: 10.1016/j.maturitas.2013.02.004.
- Saulnier DM, et al. The intestinal microbiome, probiotics and prebiotics in neurogastroenterology. Gut microbes. 2013;4:17–27. doi: 10.4161/gmic.22973.
- von Geldern G, Mowry EM. The influence of nutritional factors on the prognosis of multiple sclerosis. Nature reviews. Neurology. 2012;8:678–689. doi: 10.1038/nrneurol.2012.194.
- Camfield DA, Owen L, Scholey AB, Pipingas A, Stough C. Dairy constituents and neurocognitive health in ageing. The British journal of nutrition. 2011;106:159–174. doi: 10.1017/S0007114511000158.
- Douglas-Escobar M, Elliott E, Neu J. Effect of intestinal microbial ecology on the developing brain. JAMA pediatrics. 2013;167:374–379. doi: 10.1001/jamapediatrics.2013.497.
- Hsiao EY, et al. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell. 2013;155:1451–1463. doi: 10.1016/j.cell.2013.11.024.
- Davari S, Talaei SA, Alaei H, Salami M. Probiotics treatment improves diabetes-induced impairment of synaptic activity and cognitive function: behavioral and electrophysiological proofs for microbiome-gut-brain axis. Neuroscience. 2013;240:287–296. doi: 10.1016/j.neuroscience.2013.02.055.
- Distrutti E, et al. Modulation of intestinal microbiota by the probiotic VSL#3 resets brain gene expression and ameliorates the age-related deficit in LTP. PloS one. 2014;9:e106503. doi: 10.1371/journal.pone.0106503.
- Vinolo MA, Rodrigues HG, Nachbar RT, Curi R. Regulation of inflammation by short chain fatty acids. Nutrients. 2011;3:858–876. doi: 10.3390/nu3100858.
- Oleskin AV, Shenderov BA. Neuromodulatory effects and targets of the SCFAs and gasotransmitters produced by the human symbiotic microbiota. Microbial ecology in health and disease. 2016;27:30971.
- Orlowski M, Michaud C. Pituitary multicatalytic proteinase complex. Specificity of components and aspects of proteolytic activity. Biochemistry. 1989;28:9270–9278.
- Pfleiderer G, Celliers PG. [Isolation of an Aminopeptidase from Kidney Particles] Biochemische Zeitschrift. 1963;339:186–189.
- Oddo S, et al. Triple-transgenic model of Alzheimer’s disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron. 2003;39:409–421. doi: 10.1016/S0896-6273(03)00434-3.
- Crawford JD, Terry ME, Rourke GM. Simplification of drug dosage calculation by application of the surface area principle. Pediatrics. 1950;5:783–790.
- Nasuti C, et al. Dopaminergic system modulation, behavioral changes, and oxidative stress after neonatal administration of pyrethroids. Toxicology. 2007;229:194–205. doi: 10.1016/j.tox.2006.10.015.
- Leger M, et al. Object recognition test in mice. Nature protocols. 2013;8:2531–2537. doi: 10.1038/nprot.2013.155.
- Nasuti C, et al. Neonatal exposure to permethrin pesticide causes lifelong fear and spatial learning deficits and alters hippocampal morphology of synapses. Journal of neurodevelopmental disorders. 2014;6:7. doi: 10.1186/1866-1955-6-7.
- Kim HY, et al. Taurine in drinking water recovers learning and memory in the adult APP/PS1 mouse model of Alzheimer’s disease. Scientific reports. 2014;4:7467. doi: 10.1038/srep07467.
- Lister RG. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology. 1987;92:180–185.
- Nasuti C, et al. Effects of early life permethrin exposure on spatial working memory and on monoamine levels in different brain areas of pre-senescent rats. Toxicology. 2013;303:162–168. doi: 10.1016/j.tox.2012.09.016.
- Bell ET, et al. Faecal microbiota of cats with insulin-treated diabetes mellitus. PloS one. 2014;9:e108729. doi: 10.1371/journal.pone.0108729.
- McDonald D, et al. An improved Greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea. The ISME journal. 2012;6:610–618. doi: 10.1038/ismej.2011.139.
- Fiorini D, Boarelli MC, Gabbianelli R, Ballini R, Pacetti D. A quantitative headspace-solid-phase microextraction-gas chromatography-flame ionization detector method to analyze short chain free fatty acids in rat feces. Analytical biochemistry. 2016;508:12–14. doi: 10.1016/j.ab.2016.05.023.
- Paxinos, G. & Franklin, K. B. J. The mouse brain in stereotaxic coordinates (Academic Press, 2001).
- Liu P, et al. Characterization of a Novel Mouse Model of Alzheimer’s Disease–Amyloid Pathology and Unique beta-Amyloid Oligomer Profile. PloS one. 2015;10:e0126317. doi: 10.1371/journal.pone.0126317.
- Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical biochemistry. 1976;72:248–254. doi: 10.1016/0003-2697(76)90527-3.
- Eleuteri AM, et al. Isolation and characterization of bovine thymus multicatalytic proteinase complex. Protein expression and purification. 2000;18:160–168. doi: 10.1006/prep.1999.1187.
- Tchoupe JR, Moreau T, Gauthier F, Bieth JG. Photometric or fluorometric assay of cathepsin B, L and H and papain using substrates with an aminotrifluoromethylcoumarin leaving group. Biochimica et biophysica acta. 1991;1076:149–151. doi: 10.1016/0167-4838(91)90232-O.
- Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nature methods. 2012;9:671–675. doi: 10.1038/nmeth.2089.
- Marchini C, Angeletti M, Eleuteri AM, Fedeli A, Fioretti E. Aspirin modulates LPS-induced nitric oxide release in rat glial cells. Neuroscience letters. 2005;381:86–91. doi: 10.1016/j.neulet.2005.02.002.
- Evans SJ, et al. Dysregulation of the fibroblast growth factor system in major depression. Proceedings of the National Academy of Sciences of the United States of America. 2004;101:15506–15511. doi: 10.1073/pnas.0406788101.
- Bernard R, et al. Altered expression of glutamate signaling, growth factor, and glia genes in the locus coeruleus of patients with major depression. Molecular psychiatry. 2011;16:634–646. doi: 10.1038/mp.2010.44.
- Gaughran F, Payne J, Sedgwick PM, Cotter D, Berry M. Hippocampal FGF-2 and FGFR1 mRNA expression in major depression, schizophrenia and bipolar disorder. Brain research bulletin. 2006;70:221–227. doi: 10.1016/j.brainresbull.2006.04.008.
- Allen-Vercoe E, et al. Anaerostipes hadrus comb. nov., a dominant species within the human colonic microbiota; reclassification of Eubacterium hadrum Moore et al. 1976. Anaerobe. 2012;18:523–529. doi: 10.1016/j.anaerobe.2012.09.002.
- Sanchez-Ramos J, et al. Granulocyte colony stimulating factor decreases brain amyloid burden and reverses cognitive impairment in Alzheimer’s mice. Neuroscience. 2009;163:55–72. doi: 10.1016/j.neuroscience.2009.05.071.
- McKinnon C, Tabrizi SJ. The ubiquitin-proteasome system in neurodegeneration. Antioxidants & redox signaling. 2014;21:2302–2321. doi: 10.1089/ars.2013.5802.
- Hook G, Yu J, Toneff T, Kindy M, Hook V. Brain pyroglutamate amyloid-beta is produced by cathepsin B and is reduced by the cysteine protease inhibitor E64d, representing a potential Alzheimer’s disease therapeutic. Journal of Alzheimer’s disease: JAD. 2014;41:129–149.
- Klein DM, Felsenstein KM, Brenneman DE. Cathepsins B and L differentially regulate amyloid precursor protein processing. The Journal of pharmacology and experimental therapeutics. 2009;328:813–821. doi: 10.1124/jpet.108.147082.
- Kang R, Zeh HJ, Lotze MT, Tang D. The Beclin 1 network regulates autophagy and apoptosis. Cell death and differentiation. 2011;18:571–580. doi: 10.1038/cdd.2010.191.
- Klionsky DJ, et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy. 2012;8:445–544. doi: 10.4161/auto.19496.
- Bjorkoy G, et al. Monitoring autophagic degradation of p62/SQSTM1. Methods in enzymology. 2009;452:181–197. doi: 10.1016/S0076-6879(08)03612-4.
- Sultana R, Perluigi M, Butterfield DA. Oxidatively modified proteins in Alzheimer’s disease (AD), mild cognitive impairment and animal models of AD: role of Abeta in pathogenesis. Acta neuropathologica. 2009;118:131–150. doi: 10.1007/s00401-009-0517-0.
- Takashima A. A-beta, tau, and dementia. Journal of Alzheimer’s disease: JAD. 2009;17:729–736. doi: 10.3233/JAD-2009-1090.
- Bercik P, Collins SM, Verdu EF. Microbes and the gut-brain axis. Neurogastroenterology and motility: the official journal of the European Gastrointestinal Motility Society. 2012;24:405–413. doi: 10.1111/j.1365-2982.2012.01906.x.
- Distrutti E, Cipriani S, Mencarelli A, Renga B, Fiorucci S. Probiotics VSL#3 protect against development of visceral pain in murine model of irritable bowel syndrome. PloS one. 2013;8:e63893. doi: 10.1371/journal.pone.0063893.
- Khokhlova EV, et al. Anti-inflammatory properties of intestinal Bifidobacterium strains isolated from healthy infants. Microbiology and immunology. 2012;56:27–39. doi: 10.1111/j.1348-0421.2011.00398.x.
- Okada Y, et al. Anti-inflammatory effects of the genus Bifidobacterium on macrophages by modification of phospho-I kappaB and SOCS gene expression. International journal of experimental pathology. 2009;90:131–140. doi: 10.1111/j.1365-2613.2008.00632.x.
- Hamza E, Kittl S, Kuhnert P. Temporal induction of pro-inflammatory and regulatory cytokines in human peripheral blood mononuclear cells by Campylobacter jejuni and Campylobacter coli. PloS one. 2017;12:e0171350. doi: 10.1371/journal.pone.0171350.
- Barjesteh N, et al. Induction of chicken cytokine responses in vivo and in vitro by lipooligosaccharide of Campylobacter jejuni HS:10. Veterinary microbiology. 2013;164:122–130. doi: 10.1016/j.vetmic.2013.02.002.
- Barrett E, Ross RP, O’Toole PW, Fitzgerald GF, Stanton C. gamma-Aminobutyric acid production by culturable bacteria from the human intestine. Journal of applied microbiology. 2012;113:411–417. doi: 10.1111/j.1365-2672.2012.05344.x.
- Lyte M, Varcoe JJ, Bailey MT. Anxiogenic effect of subclinical bacterial infection in mice in the absence of overt immune activation. Physiology & behavior. 1998;65:63–68. doi: 10.1016/S0031-9384(98)00145-0.
- Kountouras J, et al. Eradication of Helicobacter pylori may be beneficial in the management of Alzheimer’s disease. Journal of neurology. 2009;256:758–767. doi: 10.1007/s00415-009-5011-z.
- Irving AJ, Harvey J. Leptin regulation of hippocampal synaptic function in health and disease. Philosophical transactions of the Royal Society of London. Series B, Biological sciences. 2014;369:20130155. doi: 10.1098/rstb.2013.0155.
- Hebda-Bauer EK, et al. 3xTg-AD mice exhibit an activated central stress axis during early-stage pathology. Journal of Alzheimer’s disease: JAD. 2013;33:407–422.
- Malcher-Lopes R, et al. Opposing crosstalk between leptin and glucocorticoids rapidly modulates synaptic excitation via endocannabinoid release. The Journal of neuroscience: the official journal of the Society for Neuroscience. 2006;26:6643–6650. doi: 10.1523/JNEUROSCI.5126-05.2006.
- Holscher C. The incretin hormones glucagonlike peptide 1 and glucose-dependent insulinotropic polypeptide are neuroprotective in mouse models of Alzheimer’s disease. Alzheimer’s & dementia: the journal of the Alzheimer’s Association. 2014;10:S47–54. doi: 10.1016/j.jalz.2013.12.009.
- Cox MA, et al. Short-chain fatty acids act as antiinflammatory mediators by regulating prostaglandin E(2) and cytokines. World journal of gastroenterology. 2009;15:5549–5557. doi: 10.3748/wjg.15.5549.
- Russo, R. et al. Gut-brain axis: Role of lipids in the regulation of inflammation, pain and CNS diseases. Current medicinal chemistry, doi:10.2174/0929867324666170216113756 (2017).
- Lei E, Vacy K, Boon WC. Fatty acids and their therapeutic potential in neurological disorders. Neurochemistry international. 2016;95:75–84. doi: 10.1016/j.neuint.2016.02.014.
- Ricobaraza A, Cuadrado-Tejedor M, Marco S, Perez-Otano I, Garcia-Osta A. Phenylbutyrate rescues dendritic spine loss associated with memory deficits in a mouse model of Alzheimer disease. Hippocampus. 2012;22:1040–1050. doi: 10.1002/hipo.20883.
- Frost G, et al. The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism. Nature communications. 2014;5:3611. doi: 10.1038/ncomms4611.
- Ohsawa K, Uchida N, Ohki K, Nakamura Y, Yokogoshi H. Lactobacillus helveticus-fermented milk improves learning and memory in mice. Nutritional neuroscience. 2015;18:232–240. doi: 10.1179/1476830514Y.0000000122.
- Keller JN, Hanni KB, Markesbery WR. Impaired proteasome function in Alzheimer’s disease. Journal of neurochemistry. 2000;75:436–439. doi: 10.1046/j.1471-4159.2000.0750436.x.
- Kitamura Y, et al. Changes of p53 in the brains of patients with Alzheimer’s disease. Biochemical and biophysical research communications. 1997;232:418–421. doi: 10.1006/bbrc.1997.6301.
- Ohyagi Y, et al. Intracellular Abeta42 activates p53 promoter: a pathway to neurodegeneration in Alzheimer’s disease. FASEB journal: official publication of the Federation of American Societies for Experimental Biology. 2005;19:255–257.
- de la Monte SM, Sohn YK, Wands JR. Correlates of p53- and Fas (CD95)-mediated apoptosis in Alzheimer’s disease. Journal of the neurological sciences. 1997;152:73–83. doi: 10.1016/S0022-510X(97)00131-7.
- Hooper C, et al. p53 is upregulated in Alzheimer’s disease and induces tau phosphorylation in HEK293a cells. Neuroscience letters. 2007;418:34–37. doi: 10.1016/j.neulet.2007.03.026.
- Cecarini V, et al. Effects of Ghrelin on the Proteolytic Pathways of Alzheimer’s Disease Neuronal Cells. Molecular neurobiology. 2015
- Ulloa F, Marti E. Wnt won the war: antagonistic role of Wnt over Shh controls dorso-ventral patterning of the vertebrate neural tube. Developmental dynamics: an official publication of the American Association of Anatomists. 2010;239:69–76.
- Aurbach EL, et al. Fibroblast growth factor 9 is a novel modulator of negative affect. Proceedings of the National Academy of Sciences of the United States of America. 2015;112:11953–11958. doi: 10.1073/pnas.1510456112.
- Nakamura S, et al. Fibroblast growth factor (FGF)-9 immunoreactivity in senile plaques. Brain research. 1998;814:222–225. doi: 10.1016/S0006-8993(98)01042-7.
- Diaz Heijtz R, et al. Normal gut microbiota modulates brain development and behavior. Proceedings of the National Academy of Sciences of the United States of America. 2011;108:3047–3052. doi: 10.1073/pnas.1010529108.
Source: PubMed